Literature DB >> 11602809

In vitro binding of Helicobacter pylori to monohexosylceramides.

M Abul-Milh1, D Barnett Foster, C A Lingwood.   

Abstract

H. pylori is the major cause of human gastritis, duodenal ulcer and thus gastric adenocarcinoma. Many glycosphingolipid species have been postulated as receptors for H. pylori and it is likely that H. pylori attachment requires multiple, perhaps sequential receptor/ligand interactions. In this study, the binding of a number of H. pylori clinical isolates, as well as stock strains, to acid and neutral glycosphingolipids separated on thin-layer chromatograms was characterized under microaerobic conditions. All H. pylori clinical isolates, laboratory strains and type culture collection strains recognized galactosylceramide (Galbeta1Cer) with ceramide containing sphingosine and hydroxylated fatty acid (type I), or non-hydroxylated fatty acid (type II), on thin-layer chromatograms and when incorporated into liposomes. The clinical isolates bound stronger to Galbeta1Cer (type II) than Galbeta1Cer (type I) on TLC, whereas lab and culture collection strains showed the opposite binding preference. A clear preference in binding to Galbeta1Cer (type I) incorporated into liposome was shown by most tested strains. Clinical isolates bound well to glucosylceramide (Glcbeta1Cer) with hydroxylated fatty acid, whereas weak binding to this glycolipid was detected with the lab and type collection strains. None of the tested strains bound Glcbeta1Cer with non-hydroxylated fatty acid on the solid surface, but some strains of both clinical or type collection origins showed weak or very weak binding in the liposome assay. A clear distinction between the binding specificity of living organisms (under microaerobic conditions) as opposed to dying organisms (under normoxic conditions) illustrates the importance of cellular physiology in this process. These studies illustrate lipid modulation of the potential receptor function of monohexosylceramides and the distinction between the receptor repertoire of H. pylori clinical isolates and cultured strains commonly used to study host-cell adhesion.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11602809     DOI: 10.1023/a:1012460824913

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  49 in total

1.  Hsp70s contain a specific sulfogalactolipid binding site. Differential aglycone influence on sulfogalactosyl ceramide binding by recombinant prokaryotic and eukaryotic hsp70 family members.

Authors:  D Mamelak; M Mylvaganam; H Whetstone; E Hartmann; W Lennarz; P B Wyrick; J Raulston; H Han; P Hoffman; C A Lingwood
Journal:  Biochemistry       Date:  2001-03-27       Impact factor: 3.162

2.  Identification of glycolipid receptors for Helicobacter pylori by TLC-immunostaining.

Authors:  T Saitoh; H Natomi; W L Zhao; K Okuzumi; K Sugano; M Iwamori; Y Nagai
Journal:  FEBS Lett       Date:  1991-05-06       Impact factor: 4.124

3.  Absence of effect of Lewis A and Lewis B expression on adherence of Helicobacter pylori to human gastric cells.

Authors:  M Clyne; B Drumm
Journal:  Gastroenterology       Date:  1997-07       Impact factor: 22.682

4.  Campylobacter pylori colonization factor shows specificity for lactosylceramide sulfate and GM3 ganglioside.

Authors:  B L Slomiany; J Piotrowski; A Samanta; K VanHorn; V L Murty; A Slomiany
Journal:  Biochem Int       Date:  1989-10

Review 5.  Gastric cancer and Helicobacter pylori: biologic and epidemiologic inconsistencies.

Authors:  R Cheli; M Crespi; G Testino; F Citarda
Journal:  J Clin Gastroenterol       Date:  1998-01       Impact factor: 3.062

6.  Epithelial attachment alters the outcome of Helicobacter pylori infection.

Authors:  J L Guruge; P G Falk; R G Lorenz; M Dans; H P Wirth; M J Blaser; D E Berg; J I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

7.  Orientation of the saccharide chains of glycolipids at the membrane surface: conformational analysis of the glucose-ceramide and the glucose-glyceride linkages using molecular mechanics (MM3).

Authors:  P G Nyholm; I Pascher
Journal:  Biochemistry       Date:  1993-02-09       Impact factor: 3.162

8.  Inhibition of Helicobacter pylori colonization by sulfated gastric mucin.

Authors:  J Piotrowski; A Slomiany; V L Murty; Z Fekete; B L Slomiany
Journal:  Biochem Int       Date:  1991-07

9.  Gastric adenocarcinoma and Helicobacter pylori infection.

Authors:  N J Talley; A R Zinsmeister; A Weaver; E P DiMagno; H A Carpenter; G I Perez-Perez; M J Blaser
Journal:  J Natl Cancer Inst       Date:  1991-12-04       Impact factor: 13.506

10.  Studies on the binding of bacteria to glycolipids. Two species of Propionibacterium apparently recognize separate epitopes on lactose of lactosylceramide.

Authors:  N Strömberg; M Ryd; A A Lindberg; K A Karlsson
Journal:  FEBS Lett       Date:  1988-05-09       Impact factor: 4.124

View more
  4 in total

1.  Effect of globotriaosyl ceramide fatty acid alpha-hydroxylation on the binding by verotoxin 1 and verotoxin 2.

Authors:  Beth Binnington; Daniel Lingwood; Anita Nutikka; Clifford A Lingwood
Journal:  Neurochem Res       Date:  2002-08       Impact factor: 3.996

2.  How cholesterol constrains glycolipid conformation for optimal recognition of Alzheimer's beta amyloid peptide (Abeta1-40).

Authors:  Nouara Yahi; Anaïs Aulas; Jacques Fantini
Journal:  PLoS One       Date:  2010-02-05       Impact factor: 3.240

3.  Glycolipid binding epitopes involved in adherence of the periodontitis-associated bacterium Porphyromonas gingivalis.

Authors:  Ulrika Hallén; Jonas Angström; Annika E Björkner
Journal:  Glycoconj J       Date:  2008-02-05       Impact factor: 2.916

4.  New microbicidal functions of tracheal glands: defective anti-infectious response to Pseudomonas aeruginosa in cystic fibrosis.

Authors:  Sonia Bastonero; Yannick Le Priol; Martine Armand; Christophe S Bernard; Martine Reynaud-Gaubert; Daniel Olive; Daniel Parzy; Sophie de Bentzmann; Christian Capo; Jean-Louis Mege
Journal:  PLoS One       Date:  2009-04-28       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.